Adapalene+ Benzoyl peroxide
Silseq is used to treat acne vulgaris.
This gel contains two active substances, adapalene and benzoyl peroxide, which work together but in a different way.
Adapalene belongs to a group of medicines called retinoids and acts specifically on the skin processes that cause acne.
Benzoyl peroxide, the second active substance, has antibacterial effects and causes softening and peeling of the outer layer of the skin.
Before starting to use this medicine, discuss it with your doctor or pharmacist.
Do not use this gel on areas of the skin where there are cuts, scrapes, sunburn, or eczema.
Be careful not to get the gel in your eyes, mouth, or nose, or other very sensitive areas of the body. If this happens, rinse the area with plenty of warm water immediately.
Avoid excessive exposure to sunlight and UV lamps.
Avoid contact between the gel and hair or colored fabrics, as the gel may discolor them.
After using this medicine, wash your hands carefully.
Do not use other anti-acne products (containing benzoyl peroxide and/or retinoids) at the same time as this gel.
Avoid using Silseq at the same time as cosmetics that irritate, dry, or peel the skin.
Tell your doctor or pharmacist about all the medicines you are taking, or have recently taken, and about any medicines you plan to take.
DO NOT USESilseq if you are pregnant or planning to become pregnant.
Your doctor can provide additional information on this.
If you become pregnant while using this medicine, treatment with it must be stopped and you should inform your doctor as soon as possible for further monitoring.
Breastfeeding
This gel can be used during breastfeeding. Avoid applying the gel to the breast area to prevent exposure of the child to the medicine.
Ask your doctor or pharmacist for advice before taking any medicine.
Not applicable.
This medicine contains 40 mg of propylene glycol (E1520) per gram of gel, corresponding to a weight/weight concentration of 4.00%.
This medicine contains 3 mg of polysorbate 80 per gram of gel, corresponding to 0.3% w/w.
Always use this medicine exactly as your doctor has told you.
If you are not sure, ask your doctor or pharmacist.
This medicine is for use in adults, adolescents, and children from 9 years of age.
This medicine is for external use only.
Apply a thin layer of gel evenly to the affected area of the skin once a day, before going to bed, avoiding contact with the eyes, mouth, and nostrils. Before applying the medicine, the skin should be clean and dry. After applying the gel, wash your hands thoroughly.
Your doctor will tell you how long to use this medicine.
If you feel that the effect of Silseq is too strong or too weak, talk to your doctor or pharmacist.
If you experience persistent skin irritation, contact your doctor. Your doctor may recommend using a moisturizing preparation, applying the gel less frequently, stopping the use of the gel for a short time, or completely stopping the use of the gel.
If you apply more gel to the skin than you should, you will not get rid of acne faster, but your skin may become irritated and red.
In the following situations, contact your doctor or go to the hospital:
Do not apply a double dose to make up for forgotten doses.
Like all medicines, Silseq can cause side effects, although not everybody gets them.
Stop using the medicine and tell your doctor immediately if you experience tightness in the throat, swelling around the eyes, face, lips, or tongue, weakness, or difficulty breathing.
Stop using the medicine if you experience hives or itching of the face or body.
The frequency of these side effects is not known.
Commonside effects (may affect up to 1 in 10 people):
Uncommonside effects (may affect up to 1 in 100 people):
Frequency not known(frequency cannot be estimated from the available data)
Skin irritation that may occur after using this medicine is usually mild or moderate, with local symptoms such as redness, dryness, peeling, or burning of the skin, as well as skin pain (stabbing pain), most pronounced in the first week of use and resolving without additional treatment.
Burns at the application site are usually superficial, but more severe cases with blistering have been reported.
If you experience any side effects, including any not listed in this leaflet, please tell your doctor or pharmacist. You can also report side effects directly to the Department of Monitoring of Adverse Reactions to Medicinal Products, Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products
Al. Jerozolimskie 181C
02-222 Warsaw
Phone: +48 22 49 21 301
Fax: +48 22 49 21 309
Website: https://smz.ezdrowie.gov.pl
You can also report side effects to the marketing authorization holder.
By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the carton and tube. The expiry date refers to the last day of that month.
Do not store above 30°C.
After first opening the tube, the medicine can be used for 6 months.
Medicines should not be disposed of via wastewater or household waste.
Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.
A homogeneous, non-transparent gel, white to very pale yellow in color.
The gel is packed in a white plastic tube with HDPE/LLDPE, with a white neck with HDPE and a peel-off type seal with aluminum, with a white cap with PP.
Pack sizes: one tube of 30 g, 45 g, or 60 g.
Not all pack sizes may be marketed.
Egis Pharmaceuticals PLC
Keresztúri út 30-38
1106 Budapest
Hungary
BELTAPHARM S.p.A
Via Stelvio 66, 20095 Cusano Milanino
Milan
Italy
Adalvo Limited
Malta Life Sciences Park, Building 1, Level 4
Sir Temi Zammit Buildings, San Gwann, SGN 3000,
Malta
Netherlands (RMS)
Silseq 1 mg/g + 25 mg/g gel
Bulgaria
Силсек 1 mg/g + 25 mg/g Гел
Czech Republic
Silseq
Hungary
Silseq 1 mg/g + 25 mg/g gél
Lithuania
Silseq 1 mg/25 mg/g gelis
Latvia
Silseq 1 mg/g/25 mg/g gels
Poland
Silseq
Romania
Silseq 1 mg/g + 25 mg/g gel
Slovakia
Silseq 1 mg/g + 25 mg/g Gél
To obtain more detailed information on this medicine, contact the local representative of the marketing authorization holder:
EGIS Polska Sp. z o.o.
ul. Komitetu Obrony Robotników 45D
02-146 Warsaw
Phone: +48 22 417 92 00
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.